Related references
Note: Only part of the references are listed.Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
BRITISH JOURNAL OF CANCER (2018)
Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease
Minna Chang et al.
CLINICAL COLORECTAL CANCER (2018)
Gallstone disease, towards a better understanding and clinical practice
Chantal Housset
CURRENT OPINION IN GASTROENTEROLOGY (2018)
Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
Seyed Alireza Taghavi et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
Yvan Hutin et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis
Jessica L. Petrick et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Bioengineered bile ducts recapitulate key cholangiocyte functions
Chen Chen et al.
BIOFABRICATION (2018)
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
Mithat Gunaydin et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2018)
Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome
Jordan M. Cloyd et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease
William A. Suk et al.
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2018)
Novel lncRNA T-UCR as a potential downstream driver of the Wnt/β-catenin pathway in hepatobiliary carcinogenesis
Maite G. Fernandez-Barrena et al.
GUT (2017)
Role of the Notch signaling in cholangiocarcinoma
Antonio Cigliano et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
The Role of Sphingosine 1-Phosphate Receptor 2 in Bile-Acid-Induced Cholangiocyte Proliferation and Cholestasis-Induced Liver Injury in Mice
Yongqing Wang et al.
HEPATOLOGY (2017)
Histopathotogical evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma
Amarpreet Bhalla et al.
HUMAN PATHOLOGY (2017)
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages
Chiara Raggi et al.
JOURNAL OF HEPATOLOGY (2017)
Development of a Potent Wound Healing Agent Based on the Liver Fluke Granulin Structural Fold
Paramjit S. Bansal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
An update on cancer risk and surveillance in primary sclerosing cholangitis
Jennifer L. Horsley-Silva et al.
LIVER INTERNATIONAL (2017)
The epidemiology of non-alcoholic fatty liver disease
Stefano Bellentani
LIVER INTERNATIONAL (2017)
ULTRASTRUCTURAL LIVER CHANGES IN THE EXPERIMENTAL THYROTOXICOSIS
Nadiya Vasylivna Pasyechko et al.
POLISH JOURNAL OF PATHOLOGY (2017)
Diagnosis of viral hepatitis
Philippa J. Easterbrook et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout
Tiejuan Shao et al.
FRONTIERS IN MICROBIOLOGY (2017)
HIV-Associated Gastrointestinal Cancer
Bjoern E. -O. Jensen et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Epidemiology and risk factors: intrahepatic cholangiocarcinoma
Amar Gupta et al.
HEPATOBILIARY SURGERY AND NUTRITION (2017)
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
Jessica L. Petrick et al.
PLOS ONE (2017)
Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
Nicha Wongjarupong et al.
BMC GASTROENTEROLOGY (2017)
The microbiome and hepatobiliary-pancreatic cancers
Kosuke Mima et al.
CANCER LETTERS (2017)
Cholangiocarcinoma
Michela Squadroni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Incidence of abnormal liver biochemical tests in hyperthyroidism
Tiffany Y. Lin et al.
CLINICAL ENDOCRINOLOGY (2017)
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
Francesco Leone et al.
CANCER (2016)
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini et al.
CLINICAL CANCER RESEARCH (2016)
TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
Maria Reich et al.
GUT (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Cholangiocarcinoma risk factors and the potential role of aspirin
Fabio Bagante et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Thyroid Hormones, Oxidative Stress, and Inflammation
Antonio Mancini et al.
MEDIATORS OF INFLAMMATION (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Outcome of surgery for recurrent pyogenic cholangitis: a single center experience
Sukanta Ray et al.
HPB (2016)
Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis
Gabriele Capurso et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
ACG Clinical Guideline: Primary Sclerosing Cholangitis
Keith D. Lindor et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Clinical presentation, risk factors and staging systems of cholangiocarcinoma
Ruben R. Plentz et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies
Hao Cai et al.
BMC CANCER (2015)
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Satdarshan Pal Monga
GASTROENTEROLOGY (2015)
Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages
Z. You et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line
Runping Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Luke Boulter et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2015)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
Juan W. Valle et al.
LANCET ONCOLOGY (2015)
Cholangiocarcinoma: from molecular biology to treatment
Ana F. Brito et al.
MEDICAL ONCOLOGY (2015)
Targeting the WNT Signaling Pathway in Cancer Therapeutics
David Tai et al.
ONCOLOGIST (2015)
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review
Hyo Jung Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies
Hao Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Bile acid signaling and biliary functions
Hannah Jones et al.
ACTA PHARMACEUTICA SINICA B (2015)
Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis
V. Bagnardi et al.
BRITISH JOURNAL OF CANCER (2015)
TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
Verena Keitel et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2015)
Molecular pathogenesis of intrahepatic cholangiocarcinoma
Jesper B. Andersen
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers
Carl Kilander et al.
ACTA ONCOLOGICA (2014)
Non-viral causes of liver cancer: Does obesity led inflammation play a role?
Badr Alzahrani et al.
CANCER LETTERS (2014)
Loss of circadian clock gene expression is associated with tumor progression in breast cancer
Cristina Cadenas et al.
CELL CYCLE (2014)
Bile acids and the gut microbiome
Jason M. Ridlon et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
M. Moehler et al.
EUROPEAN JOURNAL OF CANCER (2014)
Cholangiocarcinoma Development: The Resurgence of Bile Acids
Luca Maroni et al.
HEPATOLOGY (2014)
Desmoplastic Stroma and Cholangiocarcinoma: Clinical Implications and Therapeutic Targeting
Alphonse E. Sirica et al.
HEPATOLOGY (2014)
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma
Yuichiro Kubo et al.
HUMAN PATHOLOGY (2014)
Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia
Yasunori Sato et al.
JOURNAL OF GASTROENTEROLOGY (2014)
New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma
Tushar Patel
JOURNAL OF GASTROENTEROLOGY (2014)
Roles of liver fluke infection as risk factor for cholangiocarcinoma
Paiboon Sithithaworn et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways
Anna Melissa Schlitter et al.
MODERN PATHOLOGY (2014)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
P. McGale et al.
LANCET (2014)
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka et al.
LANCET ONCOLOGY (2014)
The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome
C. Zhai et al.
ONCOGENE (2014)
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
Jeffrey S. Ross et al.
ONCOLOGIST (2014)
Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro
Wen-Rui Wu et al.
ONCOLOGY REPORTS (2014)
Obesity and the risk of cholangiocarcinoma: a meta-analysis
Jun-Shan Li et al.
TUMOR BIOLOGY (2014)
The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus
Moira S. Lewitt et al.
JOURNAL OF CLINICAL MEDICINE (2014)
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
F. Peng et al.
BRITISH JOURNAL OF CANCER (2013)
Bile Acids Affect the Growth of Human Cholangiocarcinoma via NF-kB Pathway
Jiaqi Dai et al.
CANCER INVESTIGATION (2013)
The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer
Abigail Zabron et al.
DISEASE MODELS & MECHANISMS (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Platelet-Derived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
Massimiliano Cadamuro et al.
HEPATOLOGY (2013)
Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis
Kirsten Boonstra et al.
HEPATOLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Update on primary sclerosing cholangitis
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2013)
The role of the hepatitis viruses in cholangiocarcinoma
S. Ralphs et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
D. Sia et al.
ONCOGENE (2013)
Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: A meta-analysis
Xiao-Hua Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver
Maria Rojas-Feria et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Intraductal papillary neoplasm of the bile duct
Xue-Shuai Wan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis
Yanming Zhou et al.
BMC CANCER (2012)
Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma
H. Nordenstedt et al.
BRITISH JOURNAL OF CANCER (2012)
The Insulin-Like Growth Factor System in Cancer
S. John Weroha et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist
Bin Li et al.
FEBS JOURNAL (2012)
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism
Gabriel Frampton et al.
GUT (2012)
Sodium Iodide Symporter and Phosphatase and Tensin Homolog Deleted on Chromosome Ten Expression in Cholangiocarcinoma Analysis with Clinicopathological Parameters
Jong Han Kim et al.
GUT AND LIVER (2012)
The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract
Serge J. L. B. Zweers et al.
HEPATOLOGY (2012)
Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study
Yutaka Suzuki et al.
HEPATOLOGY RESEARCH (2012)
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
William C. Palmer et al.
JOURNAL OF HEPATOLOGY (2012)
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Jeeyun Lee et al.
LANCET ONCOLOGY (2012)
The liver fluke Opisthorchis viverrini expresses nitric oxide synthase but not gelatinases
Suksanti Prakobwong et al.
PARASITOLOGY INTERNATIONAL (2012)
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity
Vincenzo Cardinale et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
Molecular Pathogenesis of Cholangiocarcinoma
G. Fava et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma
K. Araki et al.
BRITISH JOURNAL OF CANCER (2011)
Genetic Factors in the Pathogenesis of Cholangiocarcinoma
Christopher A. Wadsworth et al.
DIGESTIVE DISEASES (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
Embryonic Ductal Plate Cells Give Rise to Cholangiocytes, Periportal Hepatocytes, and Adult Liver Progenitor Cells
Rodolphe Carpentier et al.
GASTROENTEROLOGY (2011)
Risk Factors for Cholangiocarcinoma
Gia L. Tyson et al.
HEPATOLOGY (2011)
Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma
Hyun Ah Yoon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Cholangiocarcinoma: New Insights into Disease Pathogenesis and Biology
Chiara Braconi et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2
Shin-ichi Nakanuma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
THE SODIUM IODIDE SYMPORTER ENHANCES CELL MIGRATION AND INVASION
C. Lacoste et al.
JOURNAL OF HEPATOLOGY (2010)
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2010)
Mutations in the Circadian Gene CLOCK in Colorectal Cancer
Pia Alhopuro et al.
MOLECULAR CANCER RESEARCH (2010)
Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor
A. Mancino et al.
DIGESTIVE AND LIVER DISEASE (2009)
Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature
Murad Aljiffry et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Leptin enhances cholangiocarcinoma cell growth
Giammarco Fava et al.
CANCER RESEARCH (2008)
Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells
Kazutaka Obama et al.
CLINICAL CANCER RESEARCH (2008)
Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma
Junji Komori et al.
HEPATOLOGY (2008)
c-Met targeted therapy of cholangiocarcinoma
Matei P. Socoteanu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma
Alphonse E. Sirica
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
S. A. Khan et al.
HPB (2008)
Recurrent pyogenic cholangitis with hepatolithiasis - The role of surgical therapy in North America
Wigdan Al-Sukhni et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes
F. Meng et al.
ONCOGENE (2008)
Cholanglocarcinoma in primary sclerosing cholangitis is associated with NKG2D Polymorphisms
Espen Melum et al.
HEPATOLOGY (2008)
Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures
Marko Lempinen et al.
JOURNAL OF HEPATOLOGY (2007)
Liver fluke induces cholangiocarcinoma
Banchob Sripa et al.
PLOS MEDICINE (2007)
Clinical characteristics of Caroli's syndrome
Ozlem Yonem et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study
Tania M. Welzel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing
Hajime Isomoto et al.
GASTROENTEROLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met
Kawin Leelawat et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma
Domenico Alvaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines
Fanyin Meng et al.
GASTROENTEROLOGY (2006)
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholanglocytes via oxidative DNA damage
D Komichi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells
S Kobayashi et al.
GASTROENTEROLOGY (2005)
Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: Implications for carcinogenesis
N Ishimura et al.
GASTROENTEROLOGY (2005)
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
YH Shaib et al.
GASTROENTEROLOGY (2005)
Relation of hepatolithiasis to helminthic infestation
MH Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation
ZC Zhang et al.
HEPATOLOGY (2004)
Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis
JH Yoon et al.
HEPATOLOGY (2004)
Cyclooxygenase-2 promotes human cholangiocarcinoma growth:: Evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21Waf1/cip1 and p27kip1 and cell cycle arrest
C Han et al.
CANCER RESEARCH (2004)
Cholangiocarcinoma in association with Thorotrast exposure
Andrew X. Zhu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2004)
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
NW Werneburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes
C Spirlì et al.
GASTROENTEROLOGY (2003)
Thorotrast-induced liver neoplasia: A collective review
GS Lipshutz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2002)
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes
GP Alpini et al.
HEPATOLOGY (2001)
Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines
S Ogasawara et al.
HEPATOLOGY RESEARCH (2001)
Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line
L Tadlock et al.
HEPATOLOGY (2001)
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
M Jaiswal et al.
GASTROENTEROLOGY (2001)
Share Paper
